C/EBPβ couples dopamine signalling to substance P precursor gene expression in striatal neurones

Journal of Neurochemistry

Volumn 98, Issue 5, 2006, Pages 1390-1399

  Kovács, Krisztián A ^a   Steinmann, Myriam ^a   Magistretti, Pierre J ^a,b   Halfon, Olivier ^a   Cardinaux, Jean René ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EPFL   (Switzerland)

^c Hopital de Cery   (Switzerland)

Author keywords

Addiction; Dopamine; Preprotachykinin A; Striatum; Substance P; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; DOPAMINE; NEUROKININ A; PREPROTACHYKININ; PREPROTACHYKININ A; SUBSTANCE P; UNCLASSIFIED DRUG; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MESSENGER RNA; PROTEIN PRECURSOR; TACHYKININ;

ANIMAL CELL; ARTICLE; COMPULSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; EMBRYO; GENE; GENE EXPRESSION; GENE TARGETING; MOUSE; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; POSITIVE FEEDBACK; PPT A GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DNA FOOTPRINTING; DRUG EFFECT; DRUG INTERACTION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; NERVE CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; CORPUS STRIATUM; DNA FOOTPRINTING; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYO; ENZYME INHIBITORS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; LUCIFERASES; MICE; NEURONS; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TACHYKININS; TRANSFECTION;

EID: 33746898630     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03957.x     Document Type: Article

References (69)

1. Adams D. H., Hanson G. R. and Keefe K. A. (2001) Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102, 843-851.
2. Adams D. H., Hanson G. R. and Keefe K. A. (2005) 3,4- Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum. Brain Res. Mol. Brain Res. 133, 131-142.
3. Adler J. E. and Walker P. D. (2000) Cyclic AMP regulates substance P expression in developing and mature spinal sensory neurons. J. Neurosci. Res. 59, 624-631.
4. Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D. D. and Vinson C. (1998) A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18, 967-977.
5. Alburges M. E., Ramos B. P., Bush L. and Hanson G. R. (2000) Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments. Eur. J. Pharmacol. 390, 119-126.
6. Berke J. D. and Hyman S. E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532.
7. Brami-Cherrier K., Valjent E., Garcia M., Pages C., Hipskind R. A. and Caboche J. (2002) Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J. Neurosci. 22, 8911-8921.
8. Brandon C. L. and Steiner H. (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 18, 1584-1592.
9. Campbell B. M. and Walker P. D. (2001) Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures. Brain Res. 888, 26-33.
10. Cardinaux J. R. and Magistretti P. J. (1996) Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J. Neurosci. 16, 919-929.
11. Cardinaux J. R., Magistretti P. J. and Martin J. L. (1997) Brain-derived neurotrophic factor stimulates phosphorylation of stathmin in cortical neurons. Brain Res. Mol. Brain Res. 51, 220-228.
12. Cardinaux J. R., Allaman I. and Magistretti P. J. (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29, 91-97.
13. Chen A., Muzzio I. A., Malleret G. et al. (2003) Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39, 655-669.
14. Chen J. F., Aloyo V. J. and Weiss B. (1993) Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54, 669-680.
15. Chen J., Newton S. S., Zeng L., Adams D. H., Dow A. L., Madsen T. M., Nestler E. J. and Duman R. S. (2004) Downregulation of the CCAAT-enhancer binding protein beta in DeltaFosB transgenic mice and by electroconvulsive seizures. Neuropsychopharmacology 29, 23-31.
16. Colby C. R., Whisler K., Steffen C., Nestler E. J. and Self D. W. (2003) Striatal cell type-specific overexpression of delta FosB enhances incentive for cocaine. J. Neurosci. 23, 2488-2493.
17. Cortes-Canteli M., Pignatelli M., Santos A. and Perez-Castillo A. (2002) CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J. Biol. Chem. 277, 5460-5467.
18. Das S., Grunert M., Williams L. and Vincent S. R. (1997) NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25, 227-233.
19. Elliott P. J., Nemeroff C. B. and Kilts C. D. (1986) Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens. Brain Res. 385, 379-382.
20. Futami T., Hatanaka Y., Matsushita K. and Furuya S. (1998) Expression of substance P receptor in the substantia nigra. Brain Res. Mol. Brain Res. 54, 183-198.
21. Grider J. R. (2003) Interleukin-1 beta selectively increases substance P release and augments the ascending phase of the peristaltic reflex. Neurogastroenterol. Motil. 15, 607-615.
22. Hall M. E. and Stewart J. M. (1992) The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release. Pharmacol. Biochem. Behav. 41, 75-78.
23. Huang H. Y. and Lai Y. L. (2003) Lipopolysaccharide induces preprotachykinin gene expression. Am. J. Respir. Cell Mol. Biol. 29, 606-612.
24. Iversen L. (1998) Substance P equals pain substance? Nature 392, 334-335.
25. Kageyama R., Sasai Y. and Nakanishi S. (1991) Molecular characterization of transcription factors that bind to the cAMP responsive region of the substance P precursor gene. cDNA cloning of a novel C/EBP-related factor. J. Biol. Chem. 266, 15 525-15 531.
26. Kelley A. E., Stinus L. and Iversen S. D. (1979) Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci. Lett. 11, 335-339.
27. Kelz M. B., Chen J., Carlezon W. A. Jr et al. (1999) Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401, 272-276.
28. Knowlton B. J., Mangels J. A. and Squire L. R. (1996) A neostriatal habit learning system in humans. Science 273, 1399-1402.
29. Kombian S. B., Ananthalakshmi K. V., Parvathy S. S. and Matowe W. C. (2003) Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms. J. Neurophysiol. 89, 728-737.
30. Kovacs K. A., Steinmann M., Magistretti P. J., Halfon O. and Cardinaux J. R. (2003) CCAAT/enhancer-binding protein family members recruit the coactivator creb-binding protein and trigger its phosphorylation. J. Biol. Chem. 278, 36 959-36 965.
31. Kraft M., Noailles P. and Angulo J. A. (2001) Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain. Ann. N. Y. Acad. Sci. 937, 121-131.
32. Krylov D., Olive M. and Vinson C. (1995) Extending dimerization interfaces: the bZIP basic region can form a coiled coil. EMBO J. 14, 5329-5337.
33. Kveiborg M., Sabatakos G., Chiusaroli R., Wu M., Philbrick W. M., Horne W. C. and Baron R. (2004) DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol. Cell. Biol. 24, 2820-2830.
34. Liu F. C., Takahashi H., McKay R. D. and Graybiel A. M. (1995) Dopaminergic regulation of transcription factor expression in organotypic cultures of developing striatum. J. Neurosci. 15, 2367-2384.
35. Lu X. Y., Ghasemzadeh M. B. and Kalivas P. W. (1998) Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82, 767-780.
36. Mathieu-Kia A.-M. and Besson M.-J. (1998) Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Mol. Brain Res. 54, 141-151.
37. McClung C. A., Ulery P. G., Perrotti L. I., Zachariou V., Berton O. and Nestler E. J. (2004) DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 132, 146-154.
38. Medina L. and Reiner A. (1995) Neurotransmitter organization and connectivity of the basal ganglia in vertebrates: implications for the evolution of basal ganglia. Brain Behav. Evol. 46, 235-258.
39. Menard C., Hein P., Paquin A., Savelson A. et al. (2002) An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36, 597-610.
40. Minabe Y., Emori K., Toor A., Stutzmann G. E. and Ashby C. R. Jr (1996) The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse 22, 35-45.
41. Moratalla R., Elibol B., Vallejo M. and Graybiel A. M. (1996) Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156.
42. Morrison C. F., McAllister J., Dobson S. P., Mulderry P. K. and Quinn J. P. (1994) An activator element within the preprotachykinin-A promoter. Mol. Cell. Neurosci. 5, 165-175.
43. Murtra P., Sheasby A. M., Hunt S. P. and De Felipe C. (2000) Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405, 180-183.
44. Nadeau S., Hein P., Fernandes K. J., Peterson A. C. and Miller F. D. (2005) A transcriptional role for C/EBP beta in the neuronal response to axonal injury. Mol. Cell. Neurosci. 29, 525-535.
45. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S. and Mizuno N. (1994) Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347, 249-274.
46. Nestler E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
47. Nestler E. J., Barrot M. and Self D. W. (2001) DeltaFosB: a sustained molecular switch for addiction. Proc. Natl Acad. Sci. USA 98, 11 042-11 046.
48. Niehof M., Manns M. P. and Trautwein C. (1997) CREB controls LAP/ C/EBP beta transcription. Mol. Cell. Biol. 17, 3600-3613.
49. Nye H. E., Hope B. T., Kelz M. B., Iadarola M. and Nestler E. J. (1995) Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275, 1671-1680.
50. Otsuka M. and Yoshioka K. (1993) Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73, 229-308.
51. Overton P., Elliott P. J., Hagan R. M. and Clark D. (1992) Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur. J. Pharmacol. 213, 165-166.
52. Placenza F. M., Fletcher P. J., Rotzinger S. and Vaccarino F. J. (2004) Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology (Berl.) 177, 111-120.
53. Quirion R., Shults C. W., Moody T. W., Pert C. B., Chase T. N. and O'Donohue T. L. (1983) Autoradiographic distribution of substance P receptors in rat central nervous system. Nature 303, 714-716.
54. Ramji D. P. and Foka P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575.
55. Ripley T. L., Gadd C. A., De Felipe C., Hunt S. P. and Stephens D. N. (2002) Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43, 1258-1268.
56. Schrem H., Klempnauer J. and Borlak J. (2004) Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 56, 291-330.
57. Schultz W. (1998) Predictive reward signal of dopamine neurons. J. Neurophysiol. 80, 1-27.
58. Shadiack A. M., Carlson C. D., Ding M., Hart R. P. and Jonakait G. M. (1994) Lipopolysaccharide induces substance P in sympathetic ganglia via ganglionic interleukin-1 production. J. Neuroimmunol. 49, 51-58.
59. Sterneck E. and Johnson P. F. (1998) CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J. Neurochem. 70, 2424-2433.
60. Sterneck E., Paylor R., Jackson-Lewis V., Libbey M., Przedborski S., Tessarollo L., Crawley J. N. and Johnson P. F. (1998) Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc. Natl Acad. Sci. USA 95, 10 908-10 913.
61. Stinus L., Kelley A. E. and Iversen S. D. (1978) Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature 276, 616-618.
62. Taubenfeld S. M., Milekic M. H., Monti B. and Alberini C. M. (2001) The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta. Nat. Neurosci. 4, 813-818.
63. Tobler P. N., Fiorillo C. D. and Schultz W. (2005) Adaptive coding of reward value by dopamine neurons. Science 307, 1642-1645.
64. Wang J. Q. and McGinty J. F. (1997) The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J. Pharmacol. Exp. Ther. 281, 972-982.
65. Yano M. and Steiner H. (2005) Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132, 855-865.
66. Yindeeyoungyeon W. and Schell M. A. (2000) Footprinting with an automated capillary DNA sequencer. Biotechniques 29, 1034-1041.
67. 2+/calmodulin kinases activation in hippocampal neurons. J. Biol. Chem. 273, 31 345-31 351.
68. Zhou Q. and Nyberg F. (2002) Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal. Neurosci. Lett. 320, 117-120.
69. Zhou Q., Frandberg P. A., Kindlundh A. M., Le Greves P. and Nyberg F. (2003) Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal. Peptides 24, 147-153.